Is a complete NSE/WOCKPHARMA research report available?

No complete published report is available for nse/WOCKPHARMA (NSE/WOCKPHARMA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

NSE/WOCKPHARMA (NSE/WOCKPHARMA)

National Stock Exchange of India: NSE/WOCKPHARMA · INR

₹1,904

+19.22 (+1.0%)· Recorded snapshot

Market cap	309.4B
Revenue (ttm)	36.5B
Net income (ttm)	4.1B
EPS (ttm)	₹25.2
Shares out	162.5M
P/E (trailing)	75.6x
Volume	490,640
Beta	1.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 36.5B
Net income (ttm): 4.1B
EPS (ttm): ₹25.2
P/E (trailing): 75.6x
Market cap: 309.4B

Metric	Value
Amount currency	INR
Country	India
Country code	IN
Earnings date	2026-11-02
Employees	2,564
Employees change	268
Employees growth	11.67%
Enterprise value	INR 329B
Exchange	National Stock Exchange of India
Financial currency	INR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	March
Founded	1967
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	INE049B01025
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split date	2004-04-28
Last stock split type	Forward
Market cap	INR 309.4B
Next earnings date	2026-11-02
Price	INR 1,904.00
Price currency	INR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	nse/WOCKPHARMA
Website	https://www.wockhardt.com

Metric

Value

Amount currency

INR

Country

India

Country code

Earnings date

2026-11-02

Employees

2,564

Employees change

268

Employees growth

11.67%

Enterprise value

INR 329B

Exchange

National Stock Exchange of India

Financial currency

INR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

March

Founded

1967

Industry

Drug Manufacturers - Specialty & Generic

Is primary listing

Yes

ISIN number

INE049B01025

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split date

2004-04-28

Last stock split type

Forward

Market cap

INR 309.4B

Next earnings date

2026-11-02

Price

INR 1,904.00

Price currency

INR

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

nse/WOCKPHARMA

Website

https://www.wockhardt.com

Metric	Value
Earnings yield	1.32%
EV/Earnings	79.67x
EV/EBIT	56.18x
EV/EBITDA	40.42x
EV/FCF	128.29x
EV/Sales	8.92x
FCF / EV yield	0.78%
FCF yield	0.83%
Graham number	412.28679
Graham upside	-78.44%
Industry forward P/E	33.08x
Industry P/E	38.9x
P/(FCF - SBC) ratio	122.51x
P/(OCF - SBC) ratio	79.34x
P/B ratio	5.8x
P/E ratio	75.6x
P/FCF ratio	120.58x
P/OCF ratio	78.53x
P/S ratio	8.38x
Price / tangible book value	15.37x
Price/EBITDA ratio	40.93x
Sector forward P/E	36.12x
Sector P/E	45.5x

Metric

Value

Earnings yield

1.32%

EV/Earnings

79.67x

EV/EBIT

56.18x

EV/EBITDA

40.42x

EV/FCF

128.29x

EV/Sales

8.92x

FCF / EV yield

0.78%

FCF yield

0.83%

Graham number

412.28679

Graham upside

-78.44%

Industry forward P/E

33.08x

Industry P/E

38.9x

P/(FCF - SBC) ratio

122.51x

P/(OCF - SBC) ratio

79.34x

P/B ratio

5.8x

P/E ratio

75.6x

P/FCF ratio

120.58x

P/OCF ratio

78.53x

P/S ratio

8.38x

Price / tangible book value

15.37x

Price/EBITDA ratio

40.93x

Sector forward P/E

36.12x

Sector P/E

45.5x

Metric	Value
EBIT margin	15.88%
EBITDA margin	20.48%
Effective tax rate	10.58%
FCF margin	7.34%
Gross margin	65.15%
Operating margin	15.88%
Pretax margin	12.67%
Profit margin	11.2%
Profit per employee	INR 1.6M
Profitable quarters	4
Profitable years	1
Revenue per employee	INR 14.2M
ROA	3.67%
ROA (5Y)	0.89%
ROCE	7.04%
ROE	4.01%
ROE (5Y)	-6.61%
ROIC	7.59%
ROIC (5Y)	1.6%
SBC / revenue	0.12%
Tax / revenue	1.34%

Metric

Value

EBIT margin

15.88%

EBITDA margin

20.48%

Effective tax rate

10.58%

FCF margin

7.34%

Gross margin

65.15%

Operating margin

15.88%

Pretax margin

12.67%

Profit margin

11.2%

Profit per employee

INR 1.6M

Profitable quarters

Profitable years

Revenue per employee

INR 14.2M

ROA

3.67%

ROA (5Y)

0.89%

ROCE

7.04%

ROE

4.01%

ROE (5Y)

-6.61%

ROIC

7.59%

ROIC (5Y)

1.6%

SBC / revenue

0.12%

Tax / revenue

1.34%

Metric	Value
EPS growth (QoQ)	-35.94%
EPS growth 10Y	1.15%
EPS growth quarters	4
EPS growth years	3
FCF growth 3Y	31.78%
Gross profit growth	27%
Gross profit growth (Q)	28.48%
Gross profit growth 3Y	17.34%
Gross profit growth 5Y	7.55%
Net income growth (QoQ)	-36.14%
Net income growth quarters	4
Net income growth years	3
OCF growth 10Y	18.47%
OCF growth 3Y	36.6%
Operating income growth	176.19%
Operating income growth (Q)	195.56%
Revenue growth	20.4%
Revenue growth (Q)	25.88%
Revenue growth (QoQ)	-11.86%
Revenue growth 10Y	-1.87%
Revenue growth 3Y	10.6%
Revenue growth 5Y	4.23%
Revenue growth quarters	3
Revenue growth years	3

Metric

Value

EPS growth (QoQ)

-35.94%

EPS growth 10Y

1.15%

EPS growth quarters

EPS growth years

FCF growth 3Y

31.78%

Gross profit growth

27%

Gross profit growth (Q)

28.48%

Gross profit growth 3Y

17.34%

Gross profit growth 5Y

7.55%

Net income growth (QoQ)

-36.14%

Net income growth quarters

Net income growth years

OCF growth 10Y

18.47%

OCF growth 3Y

36.6%

Operating income growth

176.19%

Operating income growth (Q)

195.56%

Revenue growth

20.4%

Revenue growth (Q)

25.88%

Revenue growth (QoQ)

-11.86%

Revenue growth 10Y

-1.87%

Revenue growth 3Y

10.6%

Revenue growth 5Y

4.23%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	INR -1.4B
Depreciation and amortization	INR 1.7B
EBIT	INR 5.8B
EBITDA	INR 7.5B
EPS	INR 25.19
FCF per share	INR 15.63
Financing cash flow	INR -540M
Free cash flow	INR 2.5B
Free cash flow minus SBC	INR 2.5B
Gross profit	INR 23.8B
Income taxes	INR 490M
Investing cash flow	INR -2.4B
Net borrowing	INR 1.5B
Net cash flow	INR 1.1B
Net income	INR 4.1B
Operating cash flow minus SBC	INR 3.9B
Operating income	INR 5.8B
Revenue	INR 36.5B
Stock-based compensation	INR 40M

Metric

Value

Capital expenditures

INR -1.4B

Depreciation and amortization

INR 1.7B

EBIT

INR 5.8B

EBITDA

INR 7.5B

EPS

INR 25.19

FCF per share

INR 15.63

Financing cash flow

INR -540M

Free cash flow

INR 2.5B

Free cash flow minus SBC

INR 2.5B

Gross profit

INR 23.8B

Income taxes

INR 490M

Investing cash flow

INR -2.4B

Net borrowing

INR 1.5B

Net cash flow

INR 1.1B

Net income

INR 4.1B

Operating cash flow minus SBC

INR 3.9B

Operating income

INR 5.8B

Revenue

INR 36.5B

Stock-based compensation

INR 40M

Metric	Value
Book value per share	INR 299.95
Debt / EBITDA	2.77
Debt / equity	0.42
Debt / FCF	8.79
Interest coverage	2.74
Net cash (debt)	INR -15.5B
Net cash / market cap	-5.07%
Net debt / EBITDA	2.08
Net debt / equity	0.29
Net debt / FCF	6.11
Piotroski F-Score	6
Shareholders' equity	INR 52.8B
Tangible book value	INR 19.9B
Tangible book value per share	INR 122.65
Total cash	INR 6.8B
Total debt	INR 22.3B
WACC	9.69%

Metric

Value

Book value per share

INR 299.95

Debt / EBITDA

2.77

Debt / equity

0.42

Debt / FCF

8.79

Interest coverage

2.74

Net cash (debt)

INR -15.5B

Net cash / market cap

-5.07%

Net debt / EBITDA

2.08

Net debt / equity

0.29

Net debt / FCF

6.11

Piotroski F-Score

Shareholders' equity

INR 52.8B

Tangible book value

INR 19.9B

Tangible book value per share

INR 122.65

Total cash

INR 6.8B

Total debt

INR 22.3B

WACC

9.69%

Metric	Value
Asset turnover	0.41
Current ratio	1.66
Inventory turnover	1.5
Quick ratio	0.78
Working capital	INR 10.8B

Metric

Value

Asset turnover

0.41

Current ratio

1.66

Inventory turnover

1.5

Quick ratio

0.78

Working capital

INR 10.8B

Metric	Value
Buyback yield / dilution	-1.03%
Dividend growth (10Y)	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	14.87%
Dividend per share	INR 0.00
Last dividend	INR 10.00
Shareholder yield	-1.03%

Metric

Value

Buyback yield / dilution

-1.03%

Dividend growth (10Y)

Dividend growth (3Y)

Dividend growth (5Y)

14.87%

Dividend per share

INR 0.00

Last dividend

INR 10.00

Shareholder yield

-1.03%

Metric	Value
10Y price change	123.16%
10Y return CAGR	9.4%
10Y total return	145.48%
150-day SMA	INR 1,812.32
15Y price change	323.58%
15Y return CAGR	11.25%
15Y total return	394.76%
1D price change	1.02%
1M price change	-15.96%
1M total return	-15.96%
1W price change	-0.12%
1W total return	-0.12%
1Y price change	47.1%
1Y return CAGR	47.13%
1Y total return	47.1%
20-day SMA	INR 1,984.80
200-day SMA	INR 1,699.44
20Y price change	384.05%
20Y return CAGR	9.28%
20Y total return	490.16%
3M price change	2.08%
3M total return	2.08%
3Y price change	751.33%
3Y return CAGR	104.16%
3Y total return	751.33%
50-day SMA	INR 2,021.31
50-day SMA vs 200-day SMA	50over200
52-week high	INR 2,422.30
52-week high date	2026-06-01
52-week low	INR 1,086.70
52-week low date	2026-03-23
5Y price change	336.95%
5Y return CAGR	36.52%
5Y total return	374.16%
6M price change	32.45%
6M total return	32.45%
All-time high	INR 2,422.30
All-time high date	2026-06-01
All-time low	INR 66.50
All-time low date	2009-04-01
Average true range (ATR)	INR 79.28
Average volume	685.7K
Beta (1Y)	1.03
Beta (2Y)	0.96
Beta (5Y)	1
Change from 52-week high	-21.4%
Change from 52-week low	75.21%
Change from all-time high	-21.4%
Change from all-time low	2,763.16%
Change from open	1.01%
Day's gap	0.01%
Dollar volume	INR 934.2M
High price	INR 1,934.00
Low price	INR 1,861.20
Monthly RSI	61.36
Open price	INR 1,885.00
Position in 52-week range	58.79%
Previous close	INR 1,884.80
Price vs 150-day SMA	5.06%
Price vs 20-day SMA	-4.07%
Price vs 200-day SMA	12.04%
Price vs 50-day SMA	-5.8%
Relative volume	0.72
RSI	43.84
Sharpe ratio	0.88
Sharpe ratio (3Y)	1.49
Sharpe ratio (5Y)	0.79
Sortino ratio	1.72
Sortino ratio (3Y)	2.86
Sortino ratio (5Y)	1.5
Volume	490.6K
Weekly RSI	52
YTD price change	31.66%
YTD total return	31.66%

Metric

Value

10Y price change

123.16%

10Y return CAGR

9.4%

10Y total return

145.48%

150-day SMA

INR 1,812.32

15Y price change

323.58%

15Y return CAGR

11.25%

15Y total return

394.76%

1D price change

1.02%

1M price change

-15.96%

1M total return

-15.96%

1W price change

-0.12%

1W total return

-0.12%

1Y price change

47.1%

1Y return CAGR

47.13%

1Y total return

47.1%

20-day SMA

INR 1,984.80

200-day SMA

INR 1,699.44

20Y price change

384.05%

20Y return CAGR

9.28%

20Y total return

490.16%

3M price change

2.08%

3M total return

2.08%

3Y price change

751.33%

3Y return CAGR

104.16%

3Y total return

751.33%

50-day SMA

INR 2,021.31

50-day SMA vs 200-day SMA

50over200

52-week high

INR 2,422.30

52-week high date

2026-06-01

52-week low

INR 1,086.70

52-week low date

2026-03-23

5Y price change

336.95%

5Y return CAGR

36.52%

5Y total return

374.16%

6M price change

32.45%

6M total return

32.45%

All-time high

INR 2,422.30

All-time high date

2026-06-01

All-time low

INR 66.50

All-time low date

2009-04-01

Average true range (ATR)

INR 79.28

Average volume

685.7K

Beta (1Y)

1.03

Beta (2Y)

0.96

Beta (5Y)

Change from 52-week high

-21.4%

Change from 52-week low

75.21%

Change from all-time high

-21.4%

Change from all-time low

2,763.16%

Change from open

1.01%

Day's gap

0.01%

Dollar volume

INR 934.2M

High price

INR 1,934.00

Low price

INR 1,861.20

Monthly RSI

61.36

Open price

INR 1,885.00

Position in 52-week range

58.79%

Previous close

INR 1,884.80

Price vs 150-day SMA

5.06%

Price vs 20-day SMA

-4.07%

Price vs 200-day SMA

12.04%

Price vs 50-day SMA

-5.8%

Relative volume

0.72

RSI

43.84

Sharpe ratio

0.88

Sharpe ratio (3Y)

1.49

Sharpe ratio (5Y)

0.79

Sortino ratio

1.72

Sortino ratio (3Y)

2.86

Sortino ratio (5Y)

1.5

Volume

490.6K

Weekly RSI

YTD price change

31.66%

YTD total return

31.66%

Metric	Value
Float	79.4M
Shares change (QoQ)	-0.37%
Shares change (YoY)	1.03%
Shares held by insiders	2.47%
Shares held by institutions	11.87%
Shares outstanding	162.5M

Metric

Value

Float

79.4M

Shares change (QoQ)

-0.37%

Shares change (YoY)

1.03%

Shares held by insiders

2.47%

Shares held by institutions

11.87%

Shares outstanding

162.5M

NSE/WOCKPHARMA (NSE/WOCKPHARMA)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/WOCKPHARMA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/WOCKPHARMA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NSE/WOCKPHARMA

Frequently asked questions